Viewing Study NCT00541034


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-26 @ 12:35 AM
Study NCT ID: NCT00541034
Status: COMPLETED
Last Update Posted: 2017-08-11
First Post: 2007-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell chronic lymphocytic leukemia View
None stage I small lymphocytic lymphoma View
None stage II small lymphocytic lymphoma View
None stage III small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View
None stage I chronic lymphocytic leukemia View
None stage II chronic lymphocytic leukemia View
None stage III chronic lymphocytic leukemia View
None stage IV chronic lymphocytic leukemia View